Drug intelligence / Profile preview

Deacetylbisacodyl

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Rectal
01

Overview

Deacetylbisacodyl (also known as desacetyl bisacodyl or DAB) is the principal active metabolite of the stimulant laxatives bisacodyl and sodium picosulfate. It is formed in the intestine by enzymatic hydrolysis of these prodrugs. Deacetylbisacodyl acts locally in the colon to stimulate peristalsis and increase secretion of mucus and electrolytes such as chloride, leading to increased water content in stool and promoting bowel movements. Its mechanism involves direct stimulation of colonic mucosa, activation of parasympathetic nerves to enhance motility, inhibition of aquaporin-3 expression (reducing water reabsorption), and stimulation of adenylate cyclase with increased cyclic AMP levels[1][5][6]. Deacetylbisacodyl is not itself marketed as a drug but is pharmacologically relevant as the bioactive form responsible for the effects seen with its parent compounds.

Other names
desacetyl bisacodylbis-(p-hydroxyphenyl)-pyridyl-2-methaneBHPM
02

Targets

AC (Adenylyl cyclase family)AQP3 (Aquaporin-3 channel protein)

Beyond the preview

Go deeper on Deacetylbisacodyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Deacetylbisacodyl.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call